Pancreatic Cancer: Medical Treatments

(asked on 8th June 2021) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he has plans to ensure that pancreatic enzyme replacement therapy is made a UK-wide priority in pancreatic cancer care.


Answered by
Jo Churchill Portrait
Jo Churchill
Minister of State (Department for Work and Pensions)
This question was answered on 18th June 2021

The National Institute for Health and Care Excellence’s guidelines recommend that pancreatic enzyme replacement therapy (PERT) should be considered for people with both operable and inoperable pancreatic cancer. The National Health Service has commissioned an audit into pancreatic cancer so that wider improvements can be made for patients and any variations in treatment, including access to PERT, can be reduced.

Reticulating Splines